Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis

Leptomeningeal carcinomatosis is a fatal manifestation of metastatic breast cancer. Investigation of intrathecal (IT) trastuzumab for leptomeningeal carcinomatosis is currently underway; however, there has been no consensus. We report on two cases of human epidermal growth factor receptor 2 positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Won-Young, Kim, Han-Jo, Kim, Kyoungha, Bae, Sang-Byung, Lee, Namsu, Lee, Kyu-Taek, Won, Jong-Ho, Park, Hee-Sook, Lee, Sang-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843730/
https://www.ncbi.nlm.nih.gov/pubmed/25761487
http://dx.doi.org/10.4143/crt.2014.234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843730/
https://www.ncbi.nlm.nih.gov/pubmed/25761487
http://dx.doi.org/10.4143/crt.2014.234

Ejemplares similares